Effects of antenatal uteroplacental hypoperfusion on neonatal microvascularisation and excitotoxin sensitivity in mice

Pediatric Research

Volumn 70, Issue 3, 2011, Pages 229-235

  Catteau, Julie ^a   Gernet, Jaine Iscia ^a   Marret, Stiphane ^a,b   Legros, Hilène ^a   Gressens, Pierre ^c   Leroux, Philippe ^a   Laudenbach, Vincent ^a,b  

^a UNIVERSITÉ DE ROUEN   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; EXCITOTOXIN; IBOTENIC ACID; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; BIRTH WEIGHT; BRAIN CORTEX; BRAIN DAMAGE; EXCITOTOXICITY; FEMALE; INTRAUTERINE GROWTH RETARDATION; LIGATION; MICROVASCULARIZATION; MICROVASCULATURE; MOUSE; NEUROTOXICITY; NEWBORN; NEWBORN PERIOD; NONHUMAN; PERINATAL PERIOD; PRENATAL PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WHITE MATTER;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD31; BRAIN; EXCITATORY AMINO ACID AGONISTS; FEMALE; FETAL GROWTH RETARDATION; HUMANS; IBOTENIC ACID; ISCHEMIA; MICE; MICROCIRCULATION; NEUROTOXINS; PLACENTA; PREGNANCY; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; REGIONAL BLOOD FLOW; UTERUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80051752445     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e318224285f     Document Type: Article

References (31)

1. Mandruzzato G, Antsaklis A, Botet F, Chervenak FA, Figueras F, Grunebaum A, Puerto B, Skupski D, Stanojevic M 2008 Intrauterine restriction (IUGR). J Perinat Med 36:277-281 (Pubitemid 351948599)
2. Goldenberg RL, Culhane JF, Iams JD, Romero R 2008 Epidemiology and causes of preterm birth. Lancet 371:75-84
3. Pallotto EK, Kilbride HW 2006 Perinatal outcome and later implications of intrauterine growth restriction. Clin Obstet Gynecol 49:257-269 (Pubitemid 44317914)
4. Volpe JJ 2009 Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 8:110-124
5. Olney JW 1993 Role of excitotoxins in developmental neuropathology. APMIS suppl 40:103-112 (Pubitemid 24052966)
6. Murphy DJ, Sellers S, MacKenzie IZ, Yudkin PL, Johnson AM 1995 Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet 346:1449-1454
7. Baud O, Zupan V, Lacaze-Masmonteil T, Audibert F, Shojaei T, Thebaud B, Ville Y, Frydman R, Dehan M 2000 The relationships between antenatal management, the cause of delivery and neonatal outcome in a large cohort of very preterm singleton infants. BJOG 107:877-884 (Pubitemid 30417344)
8. Ancel PY, Marret S, Larroque B, Arnaud C, Zupan-Simunek V, Voyer M, Roze JC, Matis J, Burguet A, Ledesert B, Andre M, Pierrat V, Kaminski M 2005 Are maternal hypertension and small-for-gestational age risk factors for severe intraventricular hemorrhage and cystic periventricular leukomalacia? Results of the EPIPAGE cohort study. Am J Obstet Gynecol 193:178-184 (Pubitemid 40991842)
9. Dirnagl U, Becker K, Meisel A 2009 Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 8:398-412
10. Dirnagl U, Simon RP, Hallenbeck JM 2003 Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 26:248-254 (Pubitemid 36556155)
11. Olivier P, Baud O, Bouslama M, Evrard P, Gressens P, Verney C 2007 Moderate growth restriction: deleterious and protective effects on white matter damage. Neurobiol Dis 26:253-263 (Pubitemid 46436501)
12. Wang X, Hagberg H, Nie C, Zhu C, Ikeda T, Mallard C 2007 Dual role of intrauterine immune challenge on neonatal and adult brain vulnerability to hypoxiaischemia. J Neuropathol Exp Neurol 66:552-561 (Pubitemid 46869697)
13. Eklind S, Mallard C, Arvidsson P, Hagberg H 2005 Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr Res 58:112-116 (Pubitemid 40967439)
14. Xi L, Taher M, Yin C, Salloum F, Kukreja RC 2004 Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1alpha and AP-1 and iNOS signaling. Am J Physiol Heart Circ Physiol 287:H2369-H2375 (Pubitemid 39557104)
15. Sergeev P, da Silva R, Lucchinetti E, Zaugg K, Pasch T, Schaub MC, Zaugg M 2004 Trigger-dependent gene expression profiles in cardiac preconditioning: evidence for distinct genetic programs in ischemic and anesthetic preconditioning. Anesthesiology 100:474-488 (Pubitemid 38268863)
16. Laudenbach V, Fontaine RH, Medja F, Carmeliet P, Hicklin DJ, Gallego J, Leroux P, Marret S, Gressens P 2007 Neonatal hypoxic preconditioning involves vascular endothelial growth factor. Neurobiol Dis 26:243-252 (Pubitemid 46442791)
17. Olivier P, Baud O, Evrard P, Gressens P, Verney C 2005 Prenatal ischemia and white matter damage in rats. J Neuropathol Exp Neurol 64:998-1006 (Pubitemid 41668929)
18. Husson I, Mesples B, Bac P, Vamecq J, Evrard P, Gressens P 2002 Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 51:82-92 (Pubitemid 34027980)
19. Laudenbach V, Mantz J, Lagercrantz H, Desmonts JM, Evrard P, Gressens P 2002 Effects of alpha (2)-adrenoceptor agonists on perinatal excitotoxic brain injury: comparison of clonidine and dexmedetomidine. Anesthesiology 96:134-141 (Pubitemid 34032493)
20. Gressens P, Marret S, Hill JM, Brenneman DE, Gozes I, Fridkin M, Evrard P 1997 Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. J Clin Invest 100:390-397 (Pubitemid 27349086)
21. Marret S, Mukendi R, Gadisseux JF, Gressens P, Evrard P 1995 Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxiclike lesions. J Neuropathol Exp Neurol 54:358-370
22. Lohela M, Bry M, Tammela T, Alitalo K 2009 VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21:154-165
23. Sentilhes L, Marret S, Leroux P, Gonzalez BJ, Laquerrière A 2011 Vascularendothelial growth factor and its high affinity receptor VEGFR-2 in the normal versus destructive lesions in human forebrain during development: an immunohistochemical comparative study. Brain Res 1385:77-86
24. Rangon CM, Fortes S, Lelievre V, Leroux P, Plaisant F, Joubert C, Lanfumey L, Cohen-Salmon C, Gressens P 2007 Chronic mild stress during gestation worsens neonatal brain lesions in mice. J Neurosci 27:7532-7540 (Pubitemid 47066578)
25. Bernaudin M, Nedelec AS, Divoux D, MacKenzie ET, Petit E, Schumann-Bard P 2002 Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 22:393-403 (Pubitemid 34273595)
26. Bernaudin M, Tang Y, Reilly M, Petit E, Sharp FR 2002 Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance. J Biol Chem 277:39728-39738 (Pubitemid 35190956)
27. Hennebert O, Laudenbach V, Laquerrière A, Verney C, Carmeliet P, Marret S, Leroux P 2005 Ontogenic study of the influence of tissue plasminogen activator (t-PA) in neonatal excitotoxic brain insult and the subsequent microglia/macrophage activation. Neuroscience 130:697-712 (Pubitemid 39601442)
28. Tsatsaris V, Goffin F, Munaut C, Brichant JF, Pignon MR, Noel A, Schaaps JP, Cabrol D, Frankenne F, Foidart JM 2003 Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 88:5555-5563 (Pubitemid 37452769)
29. Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH 2006 Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction. Am J Obstet Gynecol 195:1668-1673 (Pubitemid 44792614)
30. Boutsikou T, Malamitsi-Puchner A, Economou E, Boutsikou M, Puchner KP, Hassiakos D 2006 Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates. Early Hum Dev 82:235-239
31. Leonard H, Nassar N, Bourke J, Blair E, Mulroy S, de Klerk N, Bower C 2008 Relation between intrauterine growth and subsequent intellectual disability in a ten-year population cohort of children in Western Australia. Am J Epidemiol 167:103-111